Applied Therapeutics Inc (APLT)
4.185
-0.06
(-1.53%)
USD |
NASDAQ |
May 17, 16:00
4.185
0.00 (0.00%)
After-Hours: 16:45
Applied Therapeutics Price to Book Value: 7.106 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 7.217 |
| May 15, 2024 | 7.471 |
| May 14, 2024 | 7.879 |
| May 13, 2024 | 7.522 |
| May 10, 2024 | 7.454 |
| May 09, 2024 | 7.845 |
| May 08, 2024 | 7.998 |
| May 07, 2024 | 8.183 |
| May 06, 2024 | 8.149 |
| May 03, 2024 | 8.081 |
| May 02, 2024 | 7.690 |
| May 01, 2024 | 7.538 |
| April 30, 2024 | 7.504 |
| April 29, 2024 | 7.317 |
| April 26, 2024 | 7.266 |
| April 25, 2024 | 7.181 |
| April 24, 2024 | 7.317 |
| April 23, 2024 | 7.572 |
| April 22, 2024 | 7.487 |
| April 19, 2024 | 7.436 |
| April 18, 2024 | 8.047 |
| April 17, 2024 | 8.200 |
| April 16, 2024 | 8.743 |
| April 15, 2024 | 8.590 |
| April 12, 2024 | 8.760 |
| Date | Value |
|---|---|
| April 11, 2024 | 9.066 |
| April 10, 2024 | 9.337 |
| April 09, 2024 | 9.456 |
| April 08, 2024 | 9.609 |
| April 05, 2024 | 9.812 |
| April 04, 2024 | 10.05 |
| April 03, 2024 | 10.54 |
| April 02, 2024 | 10.81 |
| April 01, 2024 | 10.75 |
| March 31, 2024 | |
| March 28, 2024 | |
| March 27, 2024 | |
| March 26, 2024 | |
| March 25, 2024 | |
| March 22, 2024 | |
| March 21, 2024 | |
| March 20, 2024 | |
| March 19, 2024 | |
| March 18, 2024 | |
| March 15, 2024 | |
| March 14, 2024 | |
| March 13, 2024 | |
| March 12, 2024 | |
| March 11, 2024 | |
| March 08, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4752
Minimum
Jun 23 2022
36.89
Maximum
Feb 05 2020
6.228
Average
4.409
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 12.92 |
| Fate Therapeutics Inc | 1.045 |
| Viking Therapeutics Inc | 7.910 |
| Terns Pharmaceuticals Inc | 1.613 |
| Edgewise Therapeutics Inc | 3.164 |
Price to Book Value Related Metrics
| Price | 4.185 |
| Earnings Yield | -43.97% |
| Market Cap | 478.21M |